Imunon, Inc. Property, Plant and Equipment, Gross
Imunon, Inc. (IMNN) had Property, Plant and Equipment, Gross of $1.81 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-31
- 2025-12-31: Property, Plant and Equipment, Gross $1.81M.
- 2024-12-31: Property, Plant and Equipment, Gross $1.74M.
- 2023-12-31: Property, Plant and Equipment, Gross $2.85M.
- 2022-12-31: Property, Plant and Equipment, Gross $3.19M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $1.81M 10-K · filed 2026-03-31 |
| 2024-12-31 | $1.74M 10-K · filed 2026-03-31 |
| 2023-12-31 | $2.85M 10-K · filed 2025-02-27 |
| 2022-12-31 | $3.19M 10-K · filed 2024-03-28 |
| 2021-12-31 | $3.83M 10-K · filed 2023-03-30 |
| 2020-12-31 | $3.52M 10-K · filed 2022-03-31 |
| 2019-12-31 | $3.50M 10-K · filed 2021-03-19 |
| 2018-12-31 | $3.15M 10-K · filed 2020-03-25 |
| 2017-12-31 | $3.01M 10-K · filed 2019-03-29 |
| 2016-12-31 | $2.98M 10-K · filed 2018-03-27 |
| 2015-12-31 | $2.91M 10-K · filed 2017-03-24 |
| 2014-12-31 | $2.80M 10-K · filed 2016-03-30 |
| 2013-12-31 | $2.10M 10-K · filed 2015-03-12 |
| 2012-12-31 | $2.04M 10-K · filed 2014-03-13 |
| 2011-12-31 | $1.43M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |